Rep. Laura Friedman disclosed acquiring Abbott Laboratories (ABT) stock, valued at $1,001 - $15,000, through an exchange resulting from a corporate merger.
- Filer
- Hon. Laura Friedman (CA)
- Asset
- Abbott Laboratories Common Stock (ABT)
- Transaction
- Exchange
- Disclosed amount
- $1,001 - $15,000
- Transaction date
- 03/24/2026
- Notification date
- 04/03/2026
Hon. Laura Friedman disclosed a single transaction in a Periodic Transaction Report filed on April 17, 2026. The transaction, which occurred on March 24, 2026, was an exchange resulting in the acquisition of Abbott Laboratories Common Stock (ABT).
The reported value of the transaction is between $1,001 and $15,000. According to a description in the filing, the exchange was the result of a corporate merger, where shares of Exact Sciences Corp Stock (EXAS) were exchanged for the newly acquired Abbott Laboratories stock. The asset is held directly by Rep. Friedman.
Important Disclaimer
Amounts are disclosed by law as broad ranges, not exact figures - this reflects the range as filed, not a precise dollar amount. This content is summarized from a public government disclosure filing and may contain errors.
The Filing Fool is not a registered investment adviser. Nothing here is a recommendation or solicitation to buy, sell, or hold any security, nor any claim about a filer's intent or knowledge.